Wed, Jul 23, 2014, 12:51 AM EDT - U.S. Markets open in 8 hrs 39 mins


% | $
Click the to save as a favorite.

Vertex Pharmaceuticals Incorporated Message Board

  • ybdc ybdc Jul 7, 2011 9:07 AM Flag

    vrtx st at ubs at neutral

    Vertex Pharmaceuticals Started At Neutral By UBS >VRTXLast update: 7/7/2011 8:59:31 AM(END) Dow Jones NewswiresJuly 07, 2011 08:59 ET (12:59 GMT)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Slowly but surely, market analysts are beginning to learn that there is more than Incivek in the Vertex pipeline.

      [> UBS initiated VRTX with a Neutral and price target of $56 saying the co is
      poised to lead a new era of hepatitis-C virus (HCV) antivirals with the recent
      FDA approval of Incivek, which they and the Street view as a potential
      blockbuster opportunity. Further, the HCV program is complemented by a novel
      and potentially transformative cystic fibrosis program, which they believe may
      address the vast majority of CF patients. The firm is initiating coverage of
      Vertex with a Neutral rating despite a near-term and long-term positive
      stance, given valuation.<]

97.74+1.43(+1.48%)Jul 22 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.